Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance AP Magiorakos, A Srinivasan, RB Carey, Y Carmeli, ME Falagas, ... Clinical microbiology and infection 18 (3), 268-281, 2012 | 14121 | 2012 |
Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses ME Falagas, EI Pitsouni, GA Malietzis, G Pappas The FASEB journal 22 (2), 338-342, 2008 | 4829 | 2008 |
Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections ME Falagas, SK Kasiakou, LD Saravolatz Clinical infectious diseases 40 (9), 1333-1341, 2005 | 2251 | 2005 |
Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis G Pappas, N Roussos, ME Falagas International journal for parasitology 39 (12), 1385-1394, 2009 | 1435 | 2009 |
Obesity and infection ME Falagas, M Kompoti The Lancet infectious diseases 6 (7), 438-446, 2006 | 1074 | 2006 |
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies ME Falagas, SK Kasiakou Critical care 10, 1-13, 2006 | 1036 | 2006 |
Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review PI Rafailidis, EG Mourtzoukou, IC Varbobitis, ME Falagas Virology journal 5, 1-7, 2008 | 783 | 2008 |
Comparison of SCImago journal rank indicator with journal impact factor ME Falagas, VD Kouranos, R Arencibia-Jorge, DE Karageorgopoulos The FASEB journal 22 (8), 2623-2628, 2008 | 761 | 2008 |
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections DE Karageorgopoulos, ME Falagas The Lancet infectious diseases 8 (12), 751-762, 2008 | 754 | 2008 |
Fosfomycin ME Falagas, EK Vouloumanou, G Samonis, KZ Vardakas Clinical microbiology reviews 29 (2), 321-347, 2016 | 689 | 2016 |
The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa ME Falagas, PK Koletsi, IA Bliziotis Journal of medical microbiology 55 (12), 1619-1629, 2006 | 685 | 2006 |
Extended-spectrum â-lactamase-producing organisms ME Falagas, DE Karageorgopoulos Journal of Hospital infection 73 (4), 345-354, 2009 | 683 | 2009 |
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum â-lactamase producing, Enterobacteriaceae infections: a systematic review ME Falagas, AC Kastoris, AM Kapaskelis, DE Karageorgopoulos The Lancet infectious diseases 10 (1), 43-50, 2010 | 673 | 2010 |
â-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis DE Karageorgopoulos, EK Vouloumanou, F Ntziora, A Michalopoulos, ... Clinical Infectious Diseases 52 (6), 750-770, 2011 | 671 | 2011 |
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections ME Falagas, GS Tansarli, DE Karageorgopoulos, KZ Vardakas Emerging infectious diseases 20 (7), 1170, 2014 | 644 | 2014 |
Epidemiology of constipation in Europe and Oceania: a systematic review G Peppas, VG Alexiou, E Mourtzoukou, ME Falagas BMC gastroenterology 8, 1-7, 2008 | 589 | 2008 |
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? ME Falagas, IA Bliziotis International journal of antimicrobial agents 29 (6), 630-636, 2007 | 564 | 2007 |
Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations J Ariza, M Bosilkovski, A Cascio, JD Colmenero, MJ Corbel, ME Falagas, ... PLOS medicine 4 (12), e317, 2007 | 528 | 2007 |
Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis KA Polyzos, AA Konstantelias, ME Falagas Ep Europace 17 (5), 767-777, 2015 | 501 | 2015 |
Sex differences in the incidence and severity of respiratory tract infections ME Falagas, EG Mourtzoukou, KZ Vardakas Respiratory medicine 101 (9), 1845-1863, 2007 | 464 | 2007 |